Antje Barreveld, MD
Pain Medicine · Newton, MANPI 1073789079
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $44,000 of the $64,431 with a category attached, or 68.3%. Vertex accounts for 97.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $50,489 and has fallen 75.2% since, to $12,520 in 2025. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $1431.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$63K
- Medtronic$1K
- Averitas Pharma Inc.$195
- Vertos Medical, Inc.$90
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
- Scilex Pharmaceuticals Inc.$34
- plus $89 from 4 others
What the payments were for
- Consulting fees$44,00068%
- Speaking & faculty fees$16,14025%
- Travel & lodging$2,8454%
- Food & beverage$1,4462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 23 | $62,640 |
| Medtronic(2 entities) | 9 | $1,308 |
| Averitas Pharma Inc. | 3 | $195 |
| Vertos Medical, Inc. | 4 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $75 |
| Scilex Pharmaceuticals Inc. | 1 | $34 |
| Nevro Corp. | 1 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Baudax Bio Inc. | 1 | $15 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$12,386
- INTELLIS$1,060
- INTELLIS ADAPTIVESTIM$117
How this compares
$64,431 in reported general payments places this provider in the 95th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 30 | $1,766 |
| Duloxetine Hcl | 16 | $595 |
| Gabapentin | 41 | $588 |
| Celecoxib | 11 | $305 |
| Baclofen | 16 | $145 |
| Pregabalin | 12 | $137 |
| Oxycodone Hcl | 11 | $117 |
| Meloxicam | 14 | $116 |
| Diazepam | 16 | $37 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Newton
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
- Daniel VardehEast Sandwich$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.